)
EBR Systems (EBR) investor relations material
EBR Systems AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Opening remarks and agenda
Meeting opened with confirmation of quorum and introduction of board members and executives.
The agenda followed the Notice of Meeting, with voting procedures and eligibility explained.
Financial performance review
Exceeded all 2025 major clinical, regulatory, and reimbursement milestones, including FDA approval, Medicare TCET program acceptance, and CMS reimbursement at a premium price point.
Early commercial traction demonstrated with increasing physician engagement, purchasing contracts, and treated patients from Q2'25 through Q1'26.
Limited Market Release phase initiated in Q4'25, reinforcing a repeatable sales model and significant demand.
Annual financial statements for 2025 were presented for consideration.
Board and executive committee updates
Directors and executives introduced, highlighting their diverse expertise and experience in scaling early-stage technology.
Re-election of John McCutcheon and Dr. Bronwyn Evans as directors proposed and supported.
- Commercial case volumes doubled and revenue reached up to US $2.36M in Q1 2026.EBR
Q1 2026 TU10 Apr 2026 - FDA approval and U.S. launch drove $1.6M revenue but net loss reached $48.8M in 2025.EBR
Q4 202520 Mar 2026 - Shareholders voted on a reverse stock split and ratification of a prior securities issuance.EBR
EGM 202611 Mar 2026 - Only FDA-approved, fully leadless CRT device, targeting a $5.8bn US market with rapid growth.EBR
Investor presentation9 Mar 2026 - Shareholders to vote on consolidating common shares for future flexibility; ASX CDIs unaffected.EBR
EGM 202621 Jan 2026 - Leadless left ventricular pacing launches with FDA approval, strong adoption, and $5.8B TAM.EBR
44th Annual J.P. Morgan Healthcare Conference15 Jan 2026 - FDA approval, funding, and commercialization plans defined a pivotal year; key proposals were voted.EBR
AGM 202525 Nov 2025 - Q3 2025 revenue surged 201% sequentially, but net loss increased to $12.2 million.EBR
Q3 2025 TU23 Nov 2025 - FDA approval and first U.S. sales of WiSE CRT System mark a pivotal commercialization milestone.EBR
Q2 2025 TU7 Sep 2025
Next EBR Systems earnings date
Next EBR Systems earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)